More on LBRX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (9/2/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

LB Pharmaceuticals (NQ:LBRX)
Delayed: 35.84 +3.53 (10.93%)
Prev. Close $32.31  
Open$33.26 
52 Wk High$ 
52 Wk Low$ 
Day High$36.60 
Day Low$32.60 
P/E N/A  
EPS$ 
Volume799,246 


Jul 22, 2026 08:51 AM Form 424B3 LB PHARMACEUTICALS INC
Jul 22, 2026 08:15 AM Form 8-K LB PHARMACEUTICALS INC For: Jul 22
Jul 22, 2026 08:00 AM LB Pharmaceuticals moves up Phase 3 schizophrenia trial readout
Jul 22, 2026 08:00 AM LB Pharmaceuticals Announces Accelerated Timing of Topline Results from the Phase 3 NOVA-2 Trial of LB-102 in Schizophrenia
Jul 20, 2026 04:11 PM BMO Capital Starts LB Pharmaceuticals Inc (LBRX) at Outperform
Jul 16, 2026 04:02 PM Form SCHEDULE 13G LB PHARMACEUTICALS INC Filed by: JPMORGAN CHASE & CO
Jul 10, 2026 04:39 PM LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
Jul 7, 2026 05:32 AM Wolfe Research Starts LB Pharmaceuticals Inc (LBRX) at Outperform
Jun 30, 2026 08:02 AM LB Pharmaceuticals names Christopher Zergebel as SVP of clinical ops
Jun 30, 2026 08:01 AM LB Pharmaceuticals Appoints Christopher Zergebel as Senior Vice President, Clinical Operations
View All Articles

Entities mentioned with lbrx

View All Entities